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a  b  s  t  r  a  c  t
Transdiagnostic  cognitive  behaviour  therapy  (TD-CBT)  aims to  target  the  symptoms  of  multiple  disorders
whereas  disorder-speciﬁc  CBT  (DS-CBT)  targets  the  symptoms  of  principal  disorders.  This  study  com-
pared  the  relative  beneﬁts  of  internet-delivered  TD-CBT  and  DS-CBT  when  provided  in clinician-guided
(CG-CBT)  and  self-guided  (SG-CBT)  formats  for people  with  a principal  diagnosis  of  Panic  Disorder  (PD).
Participants  (n  =  145)  were  randomly  allocated  to  receive  TD-CBT  or DS-CBT  and  CG-CBT  or  SG-CBT.  Large
reductions  in  symptoms  of  PD  (Cohen’s  d ≥ 0.71; avg.  reduction  ≥  36%)  and  moderate-to-large  reduc-
tions  in symptoms  of  comorbid  depression  (Cohen’s  d  ≥ 0.71;  avg.  reduction  ≥ 33%), generalised  anxiety
disorder  (Cohen’s  d ≥  0.91;  avg.  reduction  ≥  34%)  and  social  anxiety  disorder  (Cohen’s  d ≥ 0.50;  avg.  reduc-
tion ≥ 15%)  were  found  over  the  24-month  follow-up  period.  Highlighting  their  efﬁcacy  and  acceptability,ransdiagnostic
isorder-speciﬁc
elf-guided
herapist-guided
nternet
4-month follow-up
no  marked  and  consistent  differences  were  observed  between  TD-CBT  and  DS-CBT  or CG-CBT  and  DS-CBT.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).andomized controlled trial
. Introduction
Panic Disorder (PD) is an anxiety disorder characterized by
xcessive fear of the occurrence and health implications of panic
ttacks (American Psychiatric Association, 2013). PD has a 12-
onth prevalence of 2.7% and a lifetime prevalence of 4.7% in the
nited States (Kessler, Chiu, Demler, & Walters, 2005) and an esti-
ated 12-month prevalence of 1.8% and lifetime prevalence of
.5% in Australia (McEvoy, Grove, & Slade, 2011). PD can cause
igniﬁcant functional impairment and is highly comorbid with
ther anxiety and depressive disorders (Allen et al., 2010). Cogni-
ive behavioural therapy (CBT) is effective at treating PD (Butler,
hapman, Forman, & Beck, 2006; Stewart & Chambless, 2009;
ánchez-Meca, Rosa-Alcázar, Marín-Martínez, & Gómez-Conesa,
010; Hoffman, Asnaani, Vonk, Sawyer, & Fang, 2012). Several
∗ Corresponding author at: eCentreClinic, Department of Psychology, Macquarie
niversity, New South Wales, Australia.
E-mail address: blake.dear@mq.edu.au (B.F. Dear).
ttp://dx.doi.org/10.1016/j.janxdis.2016.03.005
887-6185/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article 
/).studies have also demonstrated that internet-delivered CBT for PD
produces superior outcomes to control conditions (Klein, Richards,
& Austin, 2006), produces similar outcomes as CBT delivered in a
face-to-face format (Bergstrom et al., 2010; Carlbring et al., 2005;
Kiropoulos et al., 2008), and can be successfully delivered in rou-
tine psychiatric care (Hedman, Ljótsson, Kaldo et al., 2013; Hedman,
Ljótsson, Rück et al., 2013).
At least two different CBT treatment approaches have been used
to treat PD to date (Craske et al., 2007; McEvoy, Nathan, & Norton,
2009). The ﬁrst is a disorder-speciﬁc CBT (DS-CBT) approach, which
aims to speciﬁcally target panic symptoms and the cognitive and
behaviour processes known to contribute to PD (e.g., Salkovskis,
2004; Otto & Deveney, 2005). The second is a transdiagnostic
CBT (TD-CBT) approach, which aims to simultaneously target the
underlying cognitive and behavioural processes common across
the anxiety and depressive disorders (Barlow, Allen, & Choate,
2004; Mansell, Allison, Ed, & Roz, 2009; Goldberg, 2010; Murray
et al., 2014). There is considerable evidence from clinical trials of
the more established DS-CBT approach to the treatment for PD
(Butler et al., 2006; Hoffman et al., 2012; Sánchez-Meca et al., 2010;
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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tewart & Chambless, 2009) and the results from emerging trials of
D-CBT for PD have been encouraging (Ellard, Fairholme, Boisseau,
archione, & Barlow, 2010; Dear, Titov, Schwencke et al., 2011;
ear, Titov, Sunderland et al., 2011; Dear, Titov, Schwencke et al.,
011; Dear, Titov, Sunderland et al., 2011; Johnston, Titov, Andrews,
pence, & Dear, 2011; Johnston, Titov, Spence, Andrews, & Dear,
011; Titov, Dear, McMillan et al., 2011; Titov, Dear, Schwencke
t al., 2011; Farchione et al., 2012; Norton & Barrera, 2012). How-
ver, with the exception of several recent studies (Dear, Gandy
t al., 2015; Dear, Staples et al., 2015; Dear, Zou et al., 2015;
itov, Dear, Staples, Bennett-Levy et al., 2015; Titov, Dear, Staples,
erides et al., 2015; Dear et al., submitted), studies of TD-CBT have
nvolved relatively small numbers of participants (e.g., < 10) with
D to date. Moreover, one of the only studies to focus on prin-
ipal PD (n = 65) found evidence supporting the superiority of a
ore disorder-speciﬁc approach to PD over more transdiagnos-
ic approaches trying to also address comorbid disorders (Craske
t al., 2007). However, where other studies of transdiagnostic treat-
ent have relied on a single treatment protocol, it is important to
ote that this study employed a slightly different approach where,
n the transdiagnostic condition, clinicians could employ another
isorder-speciﬁc treatment protocol targeting the next most severe
omorbid symptoms (Craske et al., 2007). Thus, further research is
eeded to examine the relative beneﬁts of TD-CBT and DS-CBT for
anic disorder and panic symptoms ideally using larger samples.
One overarching issue facing efforts to reduce the burden of
anic disorder and other common mental health disorders is that
elatively few people seek or receive treatment (Wang et al., 2007).
his has led to recent calls for innovation in the treatment of
ommon mental health disorders (Kazdin, 2015), and one such
nnovative approach is the delivery of treatment via the internet
Andersson & Titov, 2014). Internet-delivered CBT (iCBT) employs
ll of the same principles and, apart from being delivered via
he internet, provides the same therapeutic information and skills
s traditional face-to-face CBT treatments (Andersson & Titov,
014). Reﬂecting the growing evidence for iCBT (e.g., (Andersson
 Cuijpers, 2009; Cuijpers et al., 2009; Andrews, Cuijpers, Craske,
cEvoy, & Titov, 2010), there are now major efforts to explore
he potential of iCBT for anxiety and depression as a part of rou-
ine care and mental health service provision (Mewton, Wong, &
ndrews, 2012;Ruwaard, Lange, Schrieken, Dolan, & Emmelkamp,
012; Hedman, Ljótsson, Kaldo et al., 2013; Hedman, Ljótsson, Rück
t al., 2013; Newby et al., 2013; Titov, Dear, Staples, Bennett-Levy
t al., 2015; Titov, Dear, Staples, Terides et al., 2015). Notwithstand-
ng the potential of iCBT, very little is known empirically about
hat components are necessary for iCBT to be effective, safe and
cceptable. Meta-analyses indicate that clinician-guided iCBT is
ssociated with higher completion rates and greater clinical out-
omes than self-guided iCBT (Andersson & Cuijpers, 2009; Cuijpers
t al., 2009). However, several recent trials of newer-generation
elf-guided iCBT treatments have found similar clinical outcomes
ith and without clinician-guidance (Berger, Caspar et al., 2011;
erger, Hämmerli, Gubser, & Caspar, 2011; Titov et al., 2013; Dear,
andy et al., 2015; Dear, Staples et al., 2015; Dear, Zou et al.,
015; Titov, Dear, Staples, Bennett-Levy et al., 2015; Titov, Dear,
taples, Terides et al., 2015). These newer-generation self-guided
reatments have typically been carefully developed over multiple
linical trials to work in a self-guided format and often involve
ome kind of screening assessment, patient safety monitoring
nd other measures, such as automatic emails, aimed at engaging
atients throughout treatment. Safe, acceptable and effective self-
uided iCBT treatments arguably have even more potential than
linician-guided iCBT programs for improving access to treatment.
nfortunately, although some studies have shown good outcomes
an be obtained with very little clinician contact (Klein et al., 2009), Disorders 39 (2016) 88–102 89
no studies have directly compared the acceptability or efﬁcacy of
self-guided and clinician-guided iCBT for PD.
The present study is one of four large randomized controlled tri-
als (RCTs) that explore the relative clinical efﬁcacy and acceptability
of internet-delivered transdiagnostic CBT and disorder-speciﬁc
CBT, when provided in both clinician-guided and self-guided for-
mats (Dear, Gandy et al., 2015; Dear, Staples et al., 2015; Dear,
Zou et al., 2015; Titov, Dear, Staples, Bennett-Levy et al., 2015;
Titov, Dear, Staples, Terides et al., 2015; Dear et al., submitted).
The present study employed the same design as these other tri-
als in the series and speciﬁcally sought to examine the relative
clinical efﬁcacy and acceptability of transdiagnostic (TD-CBT) and
disorder-speciﬁc (DS-CBT) for principal PD, when provided in both
clinician-guided (CG-CBT) and self-guided (SG-CBT) formats. It
was hypothesised that both TD-CBT and DS-CBT would result in
signiﬁcant reductions in symptoms of PD, but that, by targeting
underlying cognitive and behavioural processes, TD-CBT would be
superior at reducing symptoms of comorbid depression, gener-
alised anxiety and social anxiety at each time point. It was also
hypothesised that CG-CBT would be superior to SG-CBT at every
time point for both symptoms of SAD and comorbid depression,
generalised anxiety, and social anxiety.
2. Method
2.1. Participants
The study was  approved by the Human Research Ethics Com-
mittee (HREC) of Macquarie University, Sydney, Australia, and the
trial was registered on the Australian and New Zealand Clinical
Trials Registry (ANZCTR) as ACTRN12612000431820. The study
was promoted via advertisements in major newspapers across
Australia and via unpaid general advertisements by a broad range
of non-governmental organisations providing services to people
with mental health difﬁculties. This study was advertised alongside
three other studies with the same design, with each RCT targeting
people with one of four principal diagnoses, that is, Panic Disorder
(PD), Major Depressive Disorder (MDD), Generalised Anxiety Dis-
order (GAD), or Social Anxiety Disorder (SAD) (Dear, Gandy et al.,
2015; Dear, Staples et al., 2015; Dear, Zou et al., 2015; Titov, Dear,
Staples, Bennett-Levy et al., 2015; Titov, Dear, Staples, Terides et al.,
2015; Dear et al., submitted). Participants read about the study and
applied to participate via the website of the eCentreClinic (www.
ecentreclinic.org), which is a specialist research unit offering the
opportunity to receive free treatment via the internet. Interested
individuals were invited to submit an online application to partic-
ipate in the trial, which involved completing several symptom and
demographic questionnaires.
The inclusion criteria for the study were: (i) resident of Australia
aged 18–64 years of age; (ii) principal symptoms consistent with
Panic Disorder; (iii) total score ≥ 1 on the Anxiety Sensitivity Ques-
tionnaire (ANSQ) (McQuaid, Stein, McCahill, Laffaye, & Ramel,
2000), and (iv) if taking medication for anxiety or depression, being
on a stable dose for at least one month. The exclusion criteria were:
(i) experiencing an unmanaged psychotic illness; (ii) experienc-
ing very severe symptoms of depression (i.e., deﬁned as a total
score > 22 or endorsing a score > 2 to item 9 of the Patient Health
Questionnaire 9-item (PHQ9); (iii) having a history of self-harm or
suicide attempts within the last 12 months; or (iv) currently par-
ticipating in CBT. Table 1 shows the demographic characteristics of
the resultant sample.The CONSORT ﬂowchart for this trial is shown in Fig. 1. A total
of 211 people applied to participate in the trial and indicated that
symptoms of PD were their principal difﬁculty during the online
application process. Of these, 185 met  the initial inclusion criteria,
90 V.J. Fogliati et al. / Journal of Anxiety Disorders 39 (2016) 88–102
1780 ind ividu als  app lied for the  Wellb eing program with in timef rame (18/04 /12  to  09/04 /13 )
Appli cations  rej ect ed outright  (n = 106):
• Did not complete the application (n = 12)
• Endorsed suic ida l id eation  or  ps ycho tic illn ess (n  = 60)
• Non -Au str alian resid ent  or  unde r 18  years  old (n  = 13)
• Did  not endorse probl ems th at cou rses add ressed (n  = 19)
• Did  not hav e access to  a computer or  th e in ter net (n  = 2)
Appli cations  rej ect ed throug h questionnair e (n = 26):
• Did  not co mpl ete th e app lication  (n  = 18)
• Not  in  Austra lia during Cour se (n =  2)
• Outside of the age range (n = 2)
• Severe  symptom s of  dep ression  bas ed on  PHQ9  (n = 4)
185 app lican ts were con tacted for  th e telephone  in ter view and  MI NI 5.0.0 
15 app lican ts fro m 
other cou rses re ceived 
a primar y di agnosis of 
panic disorder and 
were allo cated  to  th is 
trial
155 pa rticipan ts wer e ra ndo mly assigned to the disorder  spe cif ic or 
transdiagnost ic cou rse  with or wi thout c lin ician  guid ance
211 app lican ts no min ated pan ic as th eir pri mar y con cer n and comple ted  th e 
Panic Disorder trial application
Unsuccessf ul Te lepho ne  Inte rvi ew (n = 45):
• Re cen t ch anges  to  med ication for dep ression/ anxi ety (n  = 5)
• Curr ent ly eng aged  in CBT  (n  = 8)
• De cid ed to  withdr aw app lication  (n  = 2 )
• Pri mar y di agnosis/diff icu lty not pan ic (n = 14)
• Unabl e to  meet th e cou rse  timef rame (n = 2)
• Unabl e to be cont acted  for te lephon e in ter view (n  = 14)
1463 applican ts no min ated dep ression , 
genera l anx iety, or  soc ial anx iety as  th eir 
primary concern and completed the 
applications  for one  of  th ese  altern ative  tr ials
10 pa rticipan ts did not  start l esson  1 and 
were not e lig ibl e for ana lysis
Outcom es fo r 145  parti cipa nts  were anal yzed  ba sed  on  Tr eatm ent  Approach  an d Suppor t Fo rmat 
TREATMENT APPROACH
Transdiagno sti c (TD) versus Disorder -Specif ic (D S)
SUPPORT  FORMAT
Clinician -Guided  (CG) versu s Self -Guided  (SG)
CG-CBT (n = 72)
Lesson  comple tion
Lesson  1: n = 72;  100%
Lesson 2: n = 70;    97%
Lesson 3: n = 62;    86%
Lesson 4: n = 59;    82%
Lesson 5: n = 50;    69%
2 pa rticipan ts for mally 
withdrew fro m cou rse 
Questionnair e comple tion 
Post:  n = 59;  82%
3 month: n = 57;  79%
12 month: n = 53;  74%
24 month: n = 51;  71%
TD-CBT (n = 72)
Lesson  comple tion
Lesson  1: n = 72;  100%
Lesson 2: n = 69;    96%
Lesson 3: n = 62;    86%
Lesson 4: n = 58;    81%
Lesson 5: n = 49;    68%
No part icipan ts for mally 
withdrew fro m cou rse 
Questionnair e comple tion 
Post: n = 64;  89%
3 month: n = 63;  88%
12 month: n = 59;  82%
24 month: n = 55;  76%
SG-CBT (n = 73)
Lesson  comple tion
Lesson  1: n = 73;  100%
Lesson 2: n = 69;    95%
Lesson 3: n = 62;    85%
Lesson 4: n = 58;    79%
Lesson 5: n = 50;  68%
2 pa rticipan ts for mally 
withdrew fro m cou rse 
Questionnair e comple tion 
Post:  n = 63;  86%
3 month :  n = 64;  88%
12 month :  n = 60;  82%
24 month :  n = 60;  82%
DS-CBT  (n  = 73)
Lesson  comple tion
Lesson  1: n = 73;  100%
Lesson 2: n = 69;    95%
Lesson 3: n = 62;    85%
Lesson  4:  n = 59;    81%
Lesson 5: n = 51;    70%
4 pa rticipan ts for mally 
withdrew fro m cou rse 
Questionnair e comple tion 
Post: n = 58;  80%
3 month: n = 58;  80%
12 month: n = 54;  74%
24 month: n = 56;  77%
Fig. 1. Participant ﬂow from application to 24-month follow-up.
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Table  1
Demographic characteristics of the participants.
Treatment Approach Support Format
Overall
(n = 145)
TD-CBT
(n = 72)
DS-CBT
(n = 73)
Signiﬁcance CG-CBT
(n = 72)
SG-CBT
(n = 73)
Signiﬁcance
Gender
Male 30 (21%) 19 (26%) 11 (15%) Wald’s X2 2.77 p = .096 19 (26%) 11 (15%) Wald’s X2 = 2.77, p = .096
Female 115 (79%) 53 (74%) 62 (85%) 53 (74%) 62 (85%)
Age  (years)
Mean (SD) 41.40 (11.28) 43.40 (11.23) 39.42 (11.05) Wald’s X2 = 4.23p = .040 39.42 (11.05) 43.40 (11.23) Wald’s X2 = 2.04,p = .153
Range  18–62 18–62 18–58 18–58 18–62
Marital Status
Single/Never Married 79 (27%) 13 (18%) 20 (27%) Wald’s X2 = 1.11p = .293 19 (26%) 14 (19%) Wald’s X2 = .62, p = .432
Married/De Facto 174 (60%) 51 (71%) 45 (62%) 45 (63%) 51 (70%)
Separated/Divorced/Widowed 37 (13%) 8 (11%) 8 (11%) 8 (11%) 8 (11%)
Education
High School or less 38 (26%) 14 (19%) 24 (33%) Wald’s X2 = 4.70p = .030 20 (28%) 18 (25%) Wald’s X2 = .01, p = .927
Trade/Technical Certiﬁcate 25 (17%) 11 (15%) 14 (19%) 11 (15%) 14 (19%)
Diploma/Degree 82 (57%) 47 (65%) 35 (48%) 41 (57%) 41 (56%)
Employment
Full-time/Part-time 109 (75%) 60 (83%) 49 (67%) Wald’s X2 = 5.58p = .018 72 (100%) 37 (51%) Wald’s X2 < .01, p = .997
Student  7 (5%) 4 (6%) 3 (4%) 0 (0%) 7 (10%)
Unemployed, retired or disabled 29 (20%) 8 (11%) 21 (29%) 0 (0%) 29 (40%)
Previous Mental Health Treatment 108 (75%) 53 (74%) 55 (75%) Wald’s X2 = .06, p = .811 46 (64%) 62 (85%) Wald’s X2 = 8.03, p = .005
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pCurrently Taking Medication 58 (40%) 30 (42%) 28 (38%) 
ote: TD = transdiagnostic, DS = disorder-speciﬁc, CG = clinician-guided, SG = self-gu
hich were assessed via the online application, and then partici-
ated in a telephone interview during which the Mini International
europsychiatric Interview Version 5 (MINI) (Lecrubier et al., 1997)
as administered and the inclusion criteria re-assessed. A further
5 applicants initially indicated principal difﬁculties of MDD, GAD
r SAD, during the online application but, upon interview, indicated
D was their principal difﬁculty. A total of 155 applicants met  all
nclusion criteria following the telephone interview.
.2. Design and measures
The study employed a CONSORT-revised compliant RCT where
articipants were randomized to receive one of two treatment
pproaches (Treatment Approach: TD-CBT vs DS-CBT) and one
f two support formats (Support Format: CG-CBT vs SG-CBT). All
articipants completed questionnaires at initial assessment, pre-
reatment, post-treatment and at 3, 12, and 24-month follow-up.
he primary and secondary measures were administered at each
ime point with the exception of the PDSS-SR, which due to an
dministrative error was not administered at initial assessment
ut was administered at pre-treatment and all other time-points.
onsequently, pre-treatment PDSS-SR scores were used as base-
ine in the current study. In addition, the PDSS-SR and PHQ-9 were
lso administered weekly during the treatment. To reduce burden
n participants the tertiary outcomes were not administered at
nitial assessment and the K-10 and NEO-FF-N were not admin-
stered at 24-month follow-up. All analyses, except those for the
DSS-SR and the tertiary measures, used the initial assessment
cores as baseline. Unblinded MINI diagnostic assessments were
onducted via telephone at initial assessment and again at 3-month
ollow-up. The study was powered for comparisons between the
wo treatment approaches and between the two delivery formats.
he researchers sought to recruit at least 102 participants for each
omparison arm (i.e., TD-CBT vs DS-CBT and CG-CBT vs SG-CBT)
hich, with alpha set at 0.05 and power set at 0.80, would enable
he detection of small-to-moderate (i.e., Cohen’s ds > .35) effect size
ifferences between the arms. Unfortunately, recruitment difﬁ-
ulties meant that only 132 participants with principal PD were
ecruited, providing sufﬁcient power to detect a moderate-to-large
i.e., Cohen’s ds > .50) effect size difference between the arms on the
rimary outcome of panic symptoms.d’s X2 = .17, p = .684 25 (35%) 33 (45%) Wald’s X2 = 1.65, p = .199
BT = cognitive behaviour therapy.
2.2.1. Primary measure
2.2.1.1. Panic Disorder Severity Scale-Self Report (PDSS-SR) (Houck,
Spiegel, Shear, & Rucci, 2002).. The PDSS-SR is a 7-item measure of
panic disorder symptoms. Psychometric evaluations suggest that
it has high internal consistency, good test-retest reliability and is
sensitive to treatment-related change in panic symptoms (Houck
et al., 2002). Scores range from 0 to 28 and Cronbach’s  in the
current study was. 93.
2.2.2. Secondary measures
2.2.2.1. Patient Health Questionnaire-9 Item (PHQ-9) (Kroenke,
Spitzer, & Williams, 2001).. The PHQ-9 is a 9-item measure of symp-
toms of depression based on the DSM-IV diagnostic criteria for
major depressive disorder (Kroenke et al., 2001). The PHQ-9 has
good internal consistency (Titov, Dear, McMillan et al., 2011; Titov,
Dear, Schwencke et al., 2011) and is sensitive to change (Kroenke,
Spitzer, Williams, & Lowe, 2010). Scores range from 0 to 27 and
Cronbach’s  in this study was .82.
2.2.2.2. Generalized Anxiety Disorder 7-Item Scale (GAD-7) (Spitzer,
Kroenke, Williams, & Löwe, 2006).. The GAD-7 is a 7-item measure
of the symptoms and severity of general anxiety, which is based on
the DSM-IV diagnostic criteria for GAD (Löwe et al., 2008). The GAD-
7 has good internal consistency and good convergent and divergent
validity with other anxiety and disability scales (Kroenke et al.,
2010; Dear, Titov, Schwencke et al., 2011; Dear, Titov, Sunderland
et al., 2011). Scores range from 0 to 21 and Cronbach’s  in the
current study was .88.
2.2.2.3. Mini-Social Phobia Inventory (MINI-SPIN) (Connor, Kobak,
Churchill, Katzelnick, & Davidson, 2001).. The 3-item MINI-SPIN is
a measure of social anxiety symptoms based on DSM-IV criteria
for social anxiety disorder (Connor et al., 2001; Weeks, Spokas, &
Heimberg, 2007). The MINI-SPIN has good internal consistency and
adequate convergent validity with other standardised measures of
social anxiety (Weeks et al., 2007; Osório et al., 2010). Scores range
from 0 to 15 and Cronbach’s  in this study was  .87.2.2.3. Tertiary measures
2.2.3.1. Kessler 10-item scale (K-10) (Kessler et al., 2002).. The K-10
is a ten-item measure of general psychological distress with total
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cores ≥ 22 associated with a diagnosis of anxiety and depressive
isorders (Andrews & Slade, 2001). Scores range from 10 to 50 and
ronbach’s  in the current study was .89.
.2.3.2. Sheehan Disability Scale (SDS) (Sheehan, 1983).. The SDS is a
-item measure of disability with high internal consistency (Leon,
lfson, Portera, Farber, & Sheehan, 1997). Scores range from 0 to
0 and Cronbach’s  in the present study was .89.
.2.3.3. NEO-Five Factor Inventory—Neuroticism Subscale (NEO-FFI-
) (Costa & McCrae, 1985).. The Neuroticism subscale of the NEO
s a 12-item measure of a general tendency to experience negative
motional states and sensitivity to stress (Clark, Watson, & Mineka,
994; Grifﬁth et al., 2010), which is considered a higher-order risk
actor for anxiety and depression (Cuijpers, van Straten, & Donker,
005; Spinhoven, de Rooij, Heiser, Smit, & Penninx, 2009). Scores
ange from 0 to 48 and Cronbach’s  in the current study was .75.
.2.4. Other measures
.2.4.1. Mini International Neuropsychiatric Interview Version 5.0.0
MINI) (Lecrubier et al., 1997).. The MINI is a brief diagnos-
ic interview developed to determine the presence of current
xis-I disorders using DSM-IV diagnostic criteria. It has excel-
ent inter-rater reliability and adequate concurrent validity with
he Composite International Diagnostic Interview (World Health
rganization, 1990).
.2.4.2. Treatment satisfaction and acceptability. Consistent with
revious research (Titov et al., 2013; Dear, Gandy et al., 2015;
ear, Staples et al., 2015; Dear, Zou et al., 2015), treatment satis-
action and acceptability was assessed at post-treatment via two
uestions: (1) ‘Would you feel conﬁdent in recommending this
reatment to a friend?’ and (2) ‘Was it worth your time doing the
ourse?’. Participants responded to these questions with a ‘Yes’ or
No’ response.
.3. Interventions
All participants received access to either a DS-CBT course for PD,
he Panic Course,  or a TD-CBT course, the Wellbeing Course.  The Panic
ourse was developed speciﬁcally for this trial to target symptoms
f PD and the Wellbeing Course has been previously demonstrated
s clinically efﬁcacious in treating symptoms of anxiety and depres-
ion (Titov, Dear, Johnston, & Terides, 2012; Titov et al., 2013, 2014).
onsistent with the previous trials in this series of studies (Dear,
andy et al., 2015; Dear, Staples et al., 2015; Dear, Zou et al., 2015;
itov, Dear, Staples, Bennett-Levy et al., 2015; Titov, Dear, Staples,
erides et al., 2015; Dear et al., submitted), the two courses com-
rised a similar structure and similar amounts and forms of content
o facilitate comparisons. Both include ﬁve lessons delivered online
ver eight weeks, lesson summaries and homework assignments
or each lesson, a similar number of detailed case stories, and a
imilar number of additional resources targeting symptoms such
s sleep problems and communication skills. Based on the content
nd previous results (Titov, Dear, Staples, Bennett-Levy et al., 2015;
itov, Dear, Staples, Terides et al., 2015), it is expected that reading
he ﬁrst four lessons of each course will provide an adequate ther-
peutic dose. Each lesson is presented in a slide format combining
ext and images, with approximately 60 slides per lesson and 50
ords per slide. Participants are instructed to read lessons in order
ver 8 weeks. Lessons 1, 2, 3, 4, and 5 are available at the begin-
ing of weeks 1, 2, 4, 5, and 7, respectively. This timetable provides
articipants with additional time for the most complex compo-
ents of the intervention; namely skills for managing cognitive and
ehavioural symptoms. Disorders 39 (2016) 88–102
Consistent with standard deﬁnitions (McEvoy et al., 2009) and
the other trials in this series of trials (Dear, Gandy et al., 2015;
Dear, Staples et al., 2015; Dear, Zou et al., 2015; Titov, Dear, Staples,
Bennett-Levy et al., 2015; Titov, Dear, Staples, Terides et al., 2015;
Dear et al., submitted), the TD-CBT intervention was  the same for
all participants and was not designed to treat any speciﬁc psy-
chological disorder and rather aimed to present a broad range
of therapeutic information and skills relevant to the cognitive,
physical and behavioural symptoms of psychological distress gen-
erally. Reﬂecting this, the TD-CBT intervention did not mention
speciﬁc diagnoses and all vignettes, examples and case stories were
presented to cover a broad range of situations and types of psycho-
logical distress (e.g., excessive worry, low mood, social anxieties,
and panic and strong physical sensations). In contrast, the DS-CBT
treatment was  speciﬁcally designed to target symptoms of PD and
presented all therapeutic information and skills in the context of PD
and reducing PD symptoms. Consequently, all vignettes, examples
and case stories focussed on PD and the management of associ-
ated symptoms, and no speciﬁc mention of other diagnoses or the
broader application of therapeutic skills was  made. The content
and differences between the TD-CBT and DS-CBT interventions are
summarised in Table 2.
Participants in the clinician-guided condition (CG-CBT) received
weekly contact via telephone or a secure email messaging system.
Three accredited and nationally registered psychologists and one
CBT-trained counsellor provided treatment. Based on the ﬁndings
of previous studies (Craske et al., 2009; Johnston, Titov, Andrews
et al., 2011; Johnston, Titov, Spence et al., 2011) and to minimise
therapist drift (Waller, 2009), the nature of the contact was  proto-
colised and key aims included (1) reinforcing the main messages of
each lesson, (2) answering questions, (3) reinforcing progress and
skills practice, (4) problem solving the use of skills, (5) normalis-
ing the challenges of recovery, and (6) obtaining feedback about
the participant’s perception and engagement with the course. Each
contact was  designed to take ≤ 10 min, but more time was  pro-
vided when clinically indicated. The clinicians received training in
online interventions via the training program at the eCentreClinic
and received supervision from BFD and NT during weekly individ-
ual and group supervision sessions. Participants in the self-guided
condition did not receive weekly contact, but were monitored
throughout treatment by the clinicians and were able to contact the
clinic if technical assistance was required, or if they were experienc-
ing a mental health crisis. A research assistant provided technical
support for all participants in the trial.
All participants received an email at the start of the intervention
with guidelines about the course and a recommended timetable for
working through the materials. Consistent with previous research
(Titov et al., 2013, 2014), participants also received automated
emails at the beginning of each week to inform them about addi-
tional resources and to recommend activities for that week. All
participants also received automatic emails that reinforced their
progress, congratulated them on the completion of lessons, and
reminded them about the availability of new materials when they
had not viewed the lesson within a week of it becoming available.
2.4. Statistical analyses
All analyses were conducted using SPSS version 21. Group dif-
ferences in demographic variables and diagnostic variables were
analysed using binomial and multinomial logistic regression and
general linear models analyses. The alpha signiﬁcance level for the
preliminary analyses was  adjusted from 0.05 to 0.01 as a partial
control for the large number of analyses conducted. Participants
who did not start the interventions were not included in any anal-
yses.
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Table  2
Therapeutic content and skills included within the Transdiagnostic Wellbeing Course and Disorder-Speciﬁc Panic Course.
Lesson Transdiagnostic Wellbeing Course Disorder-Speciﬁc Panic Course
Lesson Content Primary Skills Taught Additional Resources Lesson Content Primary Skills Taught Additional Resources
1 Education about the general
prevalence and symptoms of
anxiety and low mood without
mention of speciﬁc disorders.
Introduction of a CBT model
and explanation of the
functional relationship
between physical, thought and
behavioural symptoms in
psychological distress.
Instructions for identifying
their own  symptoms and how
their symptoms interact.
Transdiagnostic vignettes and
examples of anxiety and low
mood symptoms provided.
- Symptom
identiﬁcation
-  Symptom formulation
- Sleep management
- What to do in a
mental health
emergency
- Transdiagnostic case
stories
Education about the
prevalence and
symptoms of PD.
Introduction of a CBT
model and explanation
of the functional
relationship between
physical, thought and
behavioural symptoms
in PD. Instructions for
identifying their own
symptoms and how
their symptoms
interact. PD speciﬁc
vignettes and examples
of PD symptoms
provided.
-  Symptom
identiﬁcation
- Symptom
formulation
- Sleep management
- What to do in a
mental health
emergency
- PD case stories
2  Introduction to the basic
principles of cognitive therapy
and importance of managing
thoughts to manage anxiety
and low mood. Instructions for
monitoring and challenging
thoughts related to anxiety and
low mood. Transdiagnostic
vignettes and examples of
thoughts provided.
- Thought monitoring
-  Thought challenging
- Structured problem
solving
- Worry Time
-  Challenging beliefs
- Transdiagnostic case
stories
Introduction to the
basic principles of
cognitive therapy and
importance of
managing thoughts to
manage PD.
Instructions for
monitoring and
challenging thoughts.
PD speciﬁc vignettes
and examples of
thoughts provided.
- Thought monitoring
- Thought challenging
- Structured problem
solving
- Challenging beliefs
- PD case stories
3  Introduction to the physical
symptoms of hyper-arousal
and hypo-arousal and their
relationship to anxiety and low
mood. Instructions about
controlling physical symptoms
using de-arousal strategies
such as controlled breathing
and scheduling pleasant
activities. Transdiagnostic
vignettes and examples of
physical symptoms provided.
-  Controlled breathing
-  Pleasant activity
scheduling
- Risk calculation,
coping calculation
and shifting
attention
- 100 pleasant things
to do
- Transdiagnostic case
stories
Introduction to the
physical symptoms of
hyper-arousal and
their relationship to
PD. Instructions about
controlling physical
symptoms using
de-arousal strategies
such as controlled
breathing. PD speciﬁc
vignettes and examples
of physical symptoms
provided.
- Controlled breathing - Risk calculation,
coping calculation
and shifting
attention
- PD case stories
4  Introduction to the behavioural
symptoms of anxiety and low
mood. Explanation of
avoidance and safety
behaviours and their
relationship to ongoing
distress. Instructions for
graded exposure for safely
confronting fears and
increasing activity levels.
Transdiagnostic vignettes and
examples of graded exposure
provided.
-  Graded exposure
-  Behavioural
activation
- Assertive
communication
- Transdiagnostic case
stories
Introduction to the
behavioural symptoms
of PD. Explanation of
avoidance and safety
behaviours for PD.
Instructions for graded
behavioural activation
for increasing daily
activities. PD speciﬁc
vignettes and examples
of graded exposure
provided.
-  Graded exposure - Assertive
communication
- PD case stories
5  Information about the
occurrence of lapses and the
process of recovery from
anxiety and low mood.
Information about the signs of
relapse and managing lapses.
Instructions for creating a
relapse prevention plan.
Transdiagnostic vignettes and
examples of lapses and lapse
management provided.
- Relapse prevention - Transdiagnostic case
stories
Information about the
occurrence of lapses
and the process of
recovery from PD.
Information about the
signs of relapse and
managing lapses.
Instructions for
creating a relapse
prevention plan. PD
speciﬁc vignettes and
examples of lapses and
lapse management
provided.
-  Relapse prevention - PD case stories
Note: The transdiagnostic course was designed in such a way that no speciﬁc anxiety or depressive disorder was mentioned throughout the materials, vignettes, examples
and  case stories. The disorder speciﬁc course made speciﬁc mention of PD and the materials, vignettes, examples and case stories all focussed on PD.
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The generalised estimation model (GEE) modelling technique
as employed to examine changes in the symptom measures over
ime. GEE emphasizes the modelling of change in an average group
ffect over time while accounting for within-subject variance with
he speciﬁcation of a working correlation structure. Rather than
reating conditional interpretation with the use of individual inter-
epts or random slopes, as in traditional mixed linear models, the
rimary emphasis in GEE is to directly model the average group-
elated change over time (Hubbarb et al., 2010). An exchangeable
orking correlation structure and maximum likelihood estima-
ion was selected, coupled with a robust error estimation for the
urposes of model parsimony, for all GEE analyses. All GEE mod-
ls also speciﬁed a gamma  distribution with a log link response
cale to address positive skewness in the dependent variable
istributions. Importantly, in the GEE analyses, the model coefﬁ-
ients represent multiplicative change in the dependent variable
rom baseline; these coefﬁcients result in a change factor (i.e.,
xp()), which can be used to calculate the average percentage
hange of symptoms from baseline. Consistent with the principles
f intention-to-treat analyses, separate GEE models utilising ran-
om intercepts were employed to impute missing data. The same
pproach was used for the imputation of the missing binary diag-
ostic values. Speciﬁcally, probability values were imputed based
n an individual’s initial diagnostic status combined with time
y treatment condition estimates and cases demonstrating higher
umulative probability than the baseline value being imputed as
aving a diagnosis.
To maximise power and the interpretability of results, the two
reatment approaches and the two support formats were analysed
eparately; however, to ensure these analyses did not obscure
mportant patterns within the data, all higher order interactions
ere explored ﬁrst. Following these initial explorations, a system-
tic series of analyses were employed to comprehensively compare
he two treatment approaches (TD-CBT vs. DS-CBT) and the two
upport formats (CG-CBT vs. SG-CBT). First, to explore efﬁcacy
cross symptom domains, GEE analyses were conducted on the
rimary and secondary outcome variables from baseline to 24-
onth follow-up focussed on the four symptom domains (i.e.,
anic, depression, generalised anxiety, and social anxiety) among
hose meeting MINI diagnostic criteria for the related disorder
i.e., PD, MDD, GAD and SAD) at assessment. Second, to explore
fﬁcacy in terms of general psychological distress, disability and
euroticism, GEE analyses were conducted on the tertiary out-
omes from baseline to 24-month follow-up using the overall
ample data. Third, for the binary outcome variable of diagnos-
ic status, GEE analyses were conducted using a binary scale and
ogit link function implementing quasi-likelihood probability esti-
ates at each time point between groups. Fourth, to examine the
verall cumulative reduction in comorbid diagnoses, the average
ount of comorbid diagnoses was analysed over time and between
roups with a negative binomial probability distribution and a log
ink function. Finally, to explore acceptability and satisfaction, one-
ay factorial ANOVAs and chi-square analyses were conducted on
he lesson completion and treatment satisfaction data. For com-
arison and benchmarking purposes, Cohen’s d effect sizes and
5% conﬁdence intervals were calculated for the within-group and
etween-group effects based on the estimated marginal means
erived from the GEE models. The average percentage change
cross time was also calculated from the GEE analyses for each
f the outcome variables with 95% conﬁdence intervals. Impor-
antly, to accurately reﬂect percentage change, a constant of 10 was
ubtracted from K10 scores when calculating percentage change
cores. Disorders 39 (2016) 88–102
3. Results
3.1. Preliminary analyses
3.1.1. Baseline differences
Demographic characteristics of the sample are shown in Table 1.
Speciﬁc details of participant ﬂow, treatment attrition, lesson com-
pletion and questionnaire response are shown in Fig. 1. There were
no differences between the TD-CBT and DS-CBT or the CG-CBT and
SG-CBT groups on the demographic variables (ps > .01) with the
exception that a slightly higher proportion of participants in SG-
CBT group reported a history of mental health treatment compared
to participants in the CG-CBT group. Comparisons exploring dif-
ferences between participants completing and not completing the
questionnaires at post-treatment indicated that those not complet-
ing questionnaires were younger (M diff = 8.12, Wald’s X2 = 11.37,
p = .001). No other differences were found for any of the demo-
graphic variables in Table 1 or in baseline outcome measure scores
(ps ≥ .01).
3.1.2. Clinician time
There were signiﬁcant differences in clinician contact time
between CG-CBT and SG-CBT groups (F1,143 = 208.75, p < .001).
The mean clinician time per participant in CG-CBT group was
36.79 minutes (SD = 21.35), which comprised answering and mak-
ing calls (total calls = 453; range = 0–14 calls; mean time = 26.13;
SD = 23.67), as well as reading, sending and responding to secure
emails (total emails = 768; range = 0–12 emails; mean time = 10.67;
SD = 8.57). The mean total clinician time per participant for SG-CBT
was. 55 min  (SD = 1.88), which comprised answering and making
calls (total calls = 2; range = 0–1 call; mean time = .11; SD = .83), as
well as reading, sending and responding to secure emails (total
emails = 10; range = 0–2 emails; mean time = .44 SD = 1.60). This
contact was focused on assessing and managing mental health
crises rather than the provision of treatment or course-related
clinical support. No signiﬁcant differences were found between
the TD-CBT and DS-CBT in the amount of clinician time required
(F1,143 = .86, p = .356).
3.1.3. Preliminary test for higher order interactions
The GEE analyses revealed signiﬁcant Treatment Approach by
Support Format by Time interactions for symptoms of panic (PDSS-
SR: Wald’s X2 = 19.05, p = .001) and depression (PHQ-9: Wald’s
X2 = 9.86, p = .043) as well as general psychological distress (K10:
Wald’s X2 = 9.10, p = .028) and disability (SDS: Wald’s X2 = 10.78,
p = .029), but no other outcomes (GAD-7: Wald’s X2 = 9.43, p = .051;
MINI-SPIN: Wald’s X2 = 5.77, p = .217; NEO-FFI-N: Wald’s X2 = 6.36,
p = .095). Closer examination of these interactions revealed that
they were driven by small differences between conditions at one
time point or changes between two  time points, which were not
maintained and did not reﬂect a pattern of difference over time.
For example, pairwise comparisons revealed no signiﬁcant differ-
ences between the conditions in panic symptoms until 24-month
follow-up, where the disorder-speciﬁc clinician-guided condition
reported lower symptoms than both the transdiagnostic clinician-
guided condition (M diff = 3.89; p = .009) and the disorder-speciﬁc
self-guided condition (M diff = 3.19; p = .015), while the transdiag-
nostic self-guided condition reported lower symptoms than the
transdiagnostic clinician-guided condition (M diff = 3.18; p = .033).
Similarly, despite a signiﬁcant interaction effect, no differences
were found between the conditions on depression symptoms or
general distress at any time point; however, giving rise to the higher
order interaction, some minor changes were observed between
follow-up time points within some conditions, which were not
observed in the other conditions. Importantly, given the very small
sample sizes per cell (all ns ≤ 30) in these higher order analyses, the
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ssociated risk of spurious ﬁndings and the fact these changes were
ot reﬂective of a pattern of difference between conditions over
ime, these higher order interactions were not further considered.
.2. Transdiagnostic CBT (TD-CBT) versus disorder-speciﬁc CBT
DS-CBT)
The means, percentage reductions and effect sizes for the TD-
BT and DS-CBT groups are shown in Table 3.
.2.1. Outcomes across the diagnoses
.2.1.1. Panic disorder. Among those meeting diagnostic criteria
or PD (n = 132) the GEE analyses indicated a signiﬁcant effect for
ime (PDSS-SR: Wald’s X2 = 260.55, p < .001). There was no signiﬁ-
ant Time by Treatment Approach interaction for panic symptoms
PDSS-SR: Wald’s X2 = 1.62, p = .806). Pairwise comparisons indi-
ated that both groups improved from baseline to post-treatment
p < .001) and from post-treatment to 3-month follow-up (p < .001).
here were no signiﬁcant differences between the groups at any
ime point.
.2.1.2. Major depressive disorder. Among those meeting diagnostic
riteria for MDD  (n = 38) the GEE analyses indicated a signiﬁ-
ant effect for Time (PHQ-9: Wald’s X2 = 76.57, p < .001), and a
igniﬁcant Time by Treatment Approach interaction effect for
epressive symptoms (PHQ-9: Wald’s X2 = 14.59, p = .006). Pairwise
omparisons indicated that both groups improved from baseline to
ost-treatment (p < .001), and that the TD-CBT group signiﬁcantly
mproved from post-treatment to 3-month follow-up (p = .004).
here was a signiﬁcant difference between the two groups at 3-
onth follow-up (p = .032) but not at any other time point.
.2.1.3. Generalised anxiety disorder. Among those meeting diag-
ostic criteria for GAD (n = 47), GEE analyses indicated a signiﬁcant
ffect for Time (GAD-7: Wald’s X2 = 73.51, p < .001) but no signiﬁcant
ime by Treatment Approach interaction for GAD symptoms (GAD-
: Wald’s X2 = 5.17, p = .270). Pairwise comparisons indicated that
oth groups improved from baseline to post-treatment (p < .001).
here were no signiﬁcant differences between the groups at any
ime point.
.2.1.4. Social anxiety disorder. Among those meeting diagnostic
riteria for SAD (n = 39), analyses indicated a signiﬁcant effect for
ime (MINI-SPIN: Wald’s X2 = 53.46, p < .001) but no signiﬁcant Time
y Treatment Approach interaction for social anxiety symptoms
MINI-SPIN: Wald’s X2 = 4.79, p = .310). Both groups improved from
aseline to post-treatment (p < .001) and from post to 3-month
ollow-up (p = .003). There were no signiﬁcant differences between
he groups at any time point.
.2.2. Outcomes for disability, general psychological distress, and
euroticism
Across the whole sample (n = 145) there were signiﬁcant main
ffects for Time on measures of disability (SDS: Wald’s X2 = 166.20,
 < .001), general psychological distress (K-10: Wald’s X2 = 135.57,
 < .001), and neuroticism (NEO-FFI-N: Wald’s X2 = 93.37, p < .001),
ut no signiﬁcant Time by Treatment Approach interactions (SDS:
ald’s X2 = 1.06, p = .900; K-10: Wald’s X2 = 0.62, p = .890; NEO-
FI-N: Wald’s X2 = 5.63, p = .131). Pairwise comparisons indicated
hat, on all measures, both groups improved from baseline to
ost-treatment (ps < .001) and from post-treatment to 3-month
ollow-up (ps < .01). There was also a further signiﬁcant improve-
ent to 12-month follow-up on neuroticism (ps < .001). However,
here were no differences between the groups at any time point. Disorders 39 (2016) 88–102 95
3.2.3. Changes in diagnostic status
The numbers and changes in the proportion of participants
meeting formal diagnostic criteria at initial assessment and 3-
month follow-up are shown in Table 4. The GEE  analyses of
diagnoses revealed a signiﬁcant effect for Time across the diag-
noses (PD: Wald’s X2 = 67.32, p < .001; MDE; Wald’s X2 = 16.50,
p < .001; GAD: Wald’s X2 = 24.88, p < .001; SAD: Wald’s X2 = 22.83,
p < .001). No signiﬁcant Time by Treatment Approach interactions
were observed for any diagnoses (PD: Wald’s X2 = 0.15, p = .697;
MDE: Wald’s X2 = 0.67, p = .411; GAD: Wald’s X2 = 0.04, p = .835; SAD:
Wald’s X2 < 0.01, p = .989) indicating that the proportion of partici-
pants meeting diagnostic criteria reduced across both groups.
The GEE analyses focusing on average comorbid diagnoses
revealed a signiﬁcant Time effect (Wald’s X2 = 103.72, p < .001)
but no Time by Treatment Approach interaction (Wald’s X2 = 0.30,
p = .581). These analyses indicated signiﬁcant reductions in comor-
bid diagnoses amongst both groups over time.
3.2.4. Treatment completion and satisfaction rates
There was no difference in the number of lessons read by the TD-
CBT (M = 4.32; SD = 1.24) and DS-CBT groups (M = 4.30; SD = 1.16) at
post-treatment (F1,143 = .01, p = .928). Of the participants that com-
pleted the evaluation questions at post-treatment, 98% (60/61) of
the TD-CBT group and 98% (56/57) of the DS-CBT group, reported
they would recommend the course to others. Moreover, 93% (57/61)
of the TD-CBT group and 95% (54/57) of the DS-CBT group reported
participating in the course was  worth their time. There were no
signiﬁcant differences between the groups in the proportions of
participants who reported they would recommend the course or
found the course was  worth their time (X2 range = .00 to .09; p
range = .766 to .961).
3.3. Clinician-guided CBT (CG-CBT) versus self-guided CBT
(DS-CBT)
The means, standard deviations and effect sizes for the CG-CBT
and SG-CBT groups are shown in Table 5.
3.3.1. Outcomes across the diagnoses
3.3.1.1. Panic disorder. Among those meeting diagnostic criteria
for PD (n = 132), GEE analyses indicated a signiﬁcant effect for
Time (PDSS-SR: Wald’s X2 = 260.87, p < .001) but no signiﬁcant
Time by Support Format interaction for panic symptoms (PDSS-
SR: Wald’s X2 = 3.11, p = .540). Pairwise comparisons indicated that
both groups improved from baseline to post-treatment and from
post-treatment to 3-month follow-up (ps < .001). There were no
differences between the groups at any time points.
3.3.1.2. Major depressive disorder. Among those meeting diagnos-
tic criteria for MDD  (n = 38), there was a signiﬁcant effect for Time
(PHQ-9: Wald’s X2 = 56.36, p < .001), but no signiﬁcant Time by Sup-
port Format interaction effect for depressive symptoms (PHQ-9:
Wald’s X2 = 3.16, p = .531). Pairwise comparisons indicated that both
groups improved from baseline to post-treatment (p < .001). There
were no differences between the groups at any time points.
3.3.1.3. Generalised anxiety disorder. Among those meeting diag-
nostic criteria for GAD (n = 47), GEE analyses indicated a signiﬁcant
effect for Time (GAD-7: Wald’s X2 = 67.18, p < .001) but no signiﬁcant
Time by Support Format interaction for GAD symptoms (GAD-7:
Wald’s X2 = .6.90, p = .142). Both groups improved from baseline to
post-treatment (p < .001). There were no differences between the
groups at any time points.
3.3.1.4. Social anxiety disorder. Among those meeting diagnostic
criteria for SAD (n = 39), there was a signiﬁcant effect for Time
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Table 3
Means, percentage change and effect sizes: transdiagnostic (TD-CBT) versus disorder speciﬁc (DS-CBT).
Estimated  Marginal  Means  % Change  from  baseline  Within  Group  Cohen’s  d  from  baseline  Between  Group  Cohen’s  d
Baseline  Post  3mth  12mth  24mth  Post  3mth  12mth  24mth  Post  3mth  12mth  24mth  Post  3mth  12mth  24mth
Principal  Outcome
Panic  Symptomsa
DS-CBT  (n  =  68)  11.77  (5.05)
[10.63,  13.02]
7.36  (5.94)
[6.08,  8.92]
5.82  (4.97)
[4.76,  7.14]
5.41  (4.85)
[4.37,  6.70]
5.44  (5.62)
[4.25,  6.96]
37%
[24%,  48%]
50%
[39%,  60%]
54%
[43%,  63%]
54%
[41%,  64%]
.79
[.43,  1.13]
1.17
[.80,  1.53]
1.27
[.89,  1.63]
1.17
[.80,  1.53]
.02
[−.32,  .36]
−.03
[−.37,  .32]
−.04
[-.38,  .30]
−.11
[-.45,  .23]
TD-CBT (n  =  64)  12.95  (5.96)
[11.57, 14.50]
7.23  (5.79)
[5.94, 8.79]
5.94  (4.17)
[5.00, 7.05]
5.63  (5.84)
[4.36,  7.26]
6.10  (6.10)
[4.77, 7.79]
44%
[32%,  54%]
54%
[46%,  61%]
57%
[44%,  66%]
53%
[40%,  63%]
.97
[.60,  1.33]
1.36
[.97,  1.74]
1.24
[.85,  1.61]
1.14
[.76,  1.50]
Secondary Outcomes
Depression  Symptomsb
DS-CBT  (n  =  24) 12.96  (5.05)
[11.08,  15.15]
7.82  (5.00)
[6.06,  10.09]
8.17  (5.98)
[6.10, 10.94]
7.46  (5.00)
[5.71,  9.76]
8.53  (5.49)
[6.60,  11.04]
40%
[22%,  53%]
37%
[16%,  53%]
42%
[25%,  56%]
34%
[15%,  49%]
1.02
[.41,  1.61]
.87
[.26,  1.44]
1.09
[.47,  1.68]
.84
[.24,  1.42]
.02
[−.64,  .68]
.63
[−.06,  1.29]
.38
[−.30,  1.03]
.56
[−.13,  1.21]
TD-CBT (n  =  14)  13.43  (4.08)
[11.46, 15.74]
7.70  (4.75)
[5.57,  10.64]
4.92  (3.37)
[3.43,  7.05]
5.69  (4.12)
[3.90,  8.31]
5.43  (5.72)
[3.13,  9.41]
43%
[21%,  59%]
63%
[48%,  74%]
58%
[38%,  71%]
60%
[30%,  77%]
1.29
[.45,  2.07]
2.27
[1.27,  3.15]
1.89
[.95,  2.72]
1.61
[.72,  2.41]
Generalised Anxiety  Symptomsc
DS-CBT  (n  =  26)  12.85  (4.54)
[11.22, 14.71]
8.46  (4.84)
[6.79, 10.55]
8.00  (4.90)
[6.31,  10.13]
6.48  (5.30)
[4.74,  8.87]
8.42  (5.15)
[6.66,  10.65]
34%
[18%,  47%]
38%
[21%,  51%]
50%
[31%,  63%]
34%
[17%,  48%]
.94
[.35,  1.49]
1.03
[.43,  1.59]
1.29
[.68,  1.87]
.91
[.33,  1.47]
.30
[−.28,
.87]
.29
[−.29,
.87]
.10
[−.48,
.67]
.38
[.−21,
.95]TD-CBT (n  =  21) 13.91  (3.85)
[12.36, 15.64]
6.94  (5.32)
[4.99, 9.64]
6.66  (4.17)
[5.09, 8.71]
5.99  (4.95)
[4.21,  8.54]
6.56  (4.58)
[4.87,  8.84]
50%
[31%,  64%]
52%
[37%,  63%]
57%
[39%,  70%]
53%
[36%,  65%]
1.50
[.79,  2.15]
1.81
[1.06,  2.49]
1.79
[1.04,  2.46]
1.74
[1.00,  2.41]
Social Anxiety  Symptoms d
DS-CBT  (n  =  21)  8.43  (2.25)
[7.52,  9.44]
6.46  (2.57)
[5.45, 7.65]
5.48  (3.12)
[4.30, 6.98]
5.03  (2.57)
[4.05,  6.26]
4.81  (3.25)
[3.60,  6.42]
23%
[9%,  35%
35%
[17%,  49%]
40%
[26%,  52%]
43%
[24%,  57%]
.82
[.17,  1.43]
1.08
[.42,  1.71]
1.41
[.71,  2.05]
1.30
[.61,  1.93]
.28
[−.36,
.90]
.26
[−.38,
.89]
.09
[−.54,
.72]
−.23
[−.86,
.41]TD-CBT (n  =  18) 8.22  (2.63)
[7.09,  9.54]
5.60  (3.61)
[4.15,  7.54]
4.69  (2.93)
[3.52,  6.26]
4.75  (3.65)
[3.33,  6.77]
5.62  (3.78)
[4.12,  7.67]
32%
[8%,  50%]
43%
[24%,  57%]
42%
[18%,  60%]
32%
[7%,  50%]
.83
[.13,  1.49]
1.27
[.53,  1.95]
1.09
[.37,  1.76]
.80
[.10,  1.46]
Tertiary Outcomes
Disability and  Functioning  (SDS)
DS-CBT  (n  =  73)  11.92  (7.35)
[10.35,  13.72]
7.81  (7.01)
[6.36, 9.59]
6.22  (6.24)
[4.94,  7.82]
5.56  (6.41)
[4.27,  7.24]
5.58  (6.84)
[4.22,  7.39]
34%
[20%,  47%]
48%
[34%,  59%]
53%
[39%,  64%]
53%
[38%,  65%]
.57
[.24,  .90]
.84
[.49,  1.17]
.92
[.58,  1.26]
.89
[.55,  1.23]
−.01
[−.34,  .32]
.11
[−.22,  .43]
.00
[−.33,  .32]
.03
[−.30,  .35]
TD-CBT (n  =  72) 11.95  (8.99)
[10.04, 14.21]
7.88  (7.55)
[6.31, 9.84]
5.56  (5.85)
[4.36,  7.09]
5.57  (6.53)
[4.25,  7.31]
5.40  (7.21)
[3.96, 7.36]
34%
[18%,  47%]
53%
[41%,  64%]
53%
[39%,  64%]
55%
[38%,  67%]
.49
[.16  to.82]
.84
[.50,  1.18]
.82
[.48,  1.16]
.80
[.46,  1.14]
Psychological Distress  (K−10)e
DS-CBT  (n  =  73)  23.14  (6.92)
[21.61, 24.78]
19.52  (6.15)
[18.17, 20.98]
18.57  (7.01)
[17.03,  20.26]
17.51  (6.49)
[16.08,  19.05]
–  28%
[16%,  38%]
35%
[22%,  47%]
43%
[31%,  54%]
–  .55
[.22,  .88]
.66
[.32  to.99]
.84
[.50,  1.17]
–  .18
[−.15,  .50]
.25
[−.08,  .58]
.17
[−.16,  .49]
–
TD-CBT (n  =  72) 21.81  (7.72)
[20.09, 23.67]
18.38  (6.79)
[16.88, 20.01]
16.94  (5.85)
[15.63, 18.35]
16.45  (6.11)
[15.10,  17.93]
–  29%
[15%,  42%]
41%
[29%,  52%]
45%
[33%,  57%]
–  .47
[.14,  .80]
.71
[.37,  1.04]
.77
[.43,  1.10]
–
Neuroticism (NEO-FFI-N)
DS-CBT  (n  =  73)  29.06  (8.54)
[27.16, 31.08]
27.53  (8.46)
[25.65, 29.54]
25.48  (8.71)
[23.55, 27.56]
23.23  (8.54)
[21.36,  25.27]
–  5%
[−2%,  12%]
12%
[5%,  19%]
20%
[13%,  26%]
–  .18
[−.15,  .50]
.42
[.08,  .74]
.68
[.35,  1.01]
– .23
[−.09,
.56]
.08
[−.25,
.40]
−.04
[−.37,
.28]
–
TD-CBT (n  =  72)  27.92  (8.15)
[26.10,  29.87]
25.56  (8.40)
[23.69, 27.58]
24.83  (8.40)
[22.96, 26.85]
23.60  (8.74)
[21.67,  25.71]
–  8%
[1%,  15%]
11%
[4%,  18%]
15%
[8%,  22%]
–  .29
[−.04,  .61]
.37
[.04,  .70]
.51
[.18,  .84]
–
Note: Standard deviations are shown in rounded parentheses for the means and 95% conﬁdence intervals are shown in square parentheses. Percentage reductions derived from the model change factor (i.e., 1 − exp()) in the
model.  Panic, depression, generalised anxiety, and social anxiety symptoms were measured with the PDSS-SR, PHQ-9, GAD-7, and MINI-SPIN, respectively.
a Analyses use the data of participants meeting diagnostic criteria for Panic Disorder at assessment.
b Analyses use the data of participants meeting diagnostic criteria for Major Depressive Disorder at assessment.
c Analyses use the data of participants meeting diagnostic criteria for Generalised Anxiety Disorder at assessment.
d Analyses use the data of participants meeting diagnostic criteria for Social Anxiety Disorder at assessment.
e To accurately reﬂect percentage change, a constant of 10 was subtracted from K10 scores when calculating percentage change scores.
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Table 4
Proportions meeting diagnostic criteria over time for each of the groups.
TD-CBT versus DS-CBT CG-CBT versus SG-CBT
Baseline 3mth % Change from Baseline Baseline 3mth % Change from Baseline
TD-CBT DS-CBT TD-CBT DS-CBT TD-CBT DS-CBT CG-CBT SG-CBT CG-CBT SG-CBT CG-CBT SG-CBT
Diagnosis
Panic Disorder 89%
[79%,94%]
93%
[85%,97%]
40%
[30%,52%]
47%
[36%,59%]
55%
[42%,67%]
49%
[37%,61%]
90%
[81%,95%]
92%
[83%,96%]
39%
[28%,51%]
49%
[37%,60%]
57%
[44%,69%]
47%
[35%,59%]
Major Depressive
Disorder
19%
[12%,30%]
33%
[23%,44%]
1%
[0%,9%]
7%
[3%,16%]
93%
[53%,99%]
79%
[53%,91%]
32%
[22%,44%]
21%
[13%,31%]
7%
[3%,16%]
1%
[0%,9%]
78%
[51%,91%]
93%
[55%,99%]
Generalised Anxiety
Disorder
29%
[20%,41%]
36%
[26%,47%]
11%
[6%,21%]
16%
[9%,26%]
62%
[29%,81%]
56%
[28%,75%]
33%
[23%,45%]
32%
[22%,43%]
11%
[6%,21%]
16%
[9%,26%]
67%
[38%,83%]
50%
[18%,71%]
Social  Anxiety Disorder 25%
[16%,36%]
29%
[20%,40%]
10%
[5%,19%]
11%
[6%,21%]
61%
[24%,81%]
60% [27%,79%] 32%
[22%,44%]
22%
[14%,33%]
14%
[8%,24%]
7%
[3%,16%]
57%
[25%,76%]
67%
[28%,85%]
Comorbid Diagnoses
Average 1.62 1.90 0.62 0.80 62%
[50%,71%]
58%
[46%,67%]
1.87 1.65 0.70 0.72 62%
[51%,71%]
56%
[43%,66%]
Frequencya
0 8%
[4%,17%]
1%
[0%,9%]
51%
[40%,63%]
44%
[33%,56%]
– – 4%
[1%,12%]
5%
[2%,14%]
49%
[37%,60%]
47%
[36%,59%]
– –
1  40%
[30%,52%]
42%
[32%,54%]
36%
[26%,48%]
35%
[25%,46%]
– – 39%
[28%,51%]
44%
[33%,55%]
35%
[25%,46%]
36%
[26%,48%]
– –
2  36%
[26%,48%]
29%
[20%,40%]
11%
[6%,21%]
17%
[10%,27%]
– – 31%
[21%,42%]
34%
[24%,46%]
14%
[8%,24%]
14%
[8%,24%]
– –
3  11%
[6%,21%]
19%
[12%,30%]
1%
[0%,9%]
4%
[1%,12%]
– – 18%
[11%,29%]
12%
[7%,22%]
3%
[1%,10%]
3%
[1%,10%]
– –
Note: 95% conﬁdence intervals of estimates are shown in parentheses both for estimates of proportions of participants meeting diagnostic criteria and for percentage change.
a The frequency of comorbid diagnoses over time was  estimated employing binary logistic regressions to provide estimates of frequency with 95% conﬁdence intervals rather than simple raw counts.
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Table 5
Means, percentage change and effect sizes: clinician-guided (CG-CBT) versus self-guided (SG-CBT).
Estimated  Marginal  Means  % Change  from  baseline  Within  Group  Cohen’s  d  from  baseline  Between  Group  Cohen’s  d
Baseline  Post  3mth  12mth  24mth  Post  3mth  12mth  24mth  Post  3mth  12mth  24mth  Post  3mth  12mth  24mth
Principal  Outcome
Panic  Symptomsa
CG-CBT  (n  =  65)  12.32  (5.80)
[10.98,  13.83]
7.94  (6.45)
[6.51,  9.67]
6.08  (4.76)
[5.02,  7.36]
5.53  (5.80)
[4.28,  7.14]
5.70 (6.21)
[4.38,  7.42]
36%
[22%,  47%]
51%
[40%,  59%]
55%
[42%,  65%]
54%
[40%,  65%]
.71
[.36,  1.06]
1.18
[.80, 1.54]
1.17
[.79,  1.54]
1.10
[.73,  1.46]
.22
[−.13,  .56]
.08
[−.26,  .43]
.01
[−.34,  .35]
−.02
[−.36,  .32]
SG-CBT (n  =  67)  12.36  (5.24)
[11.17,  13.68]
6.68  (5.16)
[5.55,  8.04]
5.69  (4.42)
[4.73, 6.85]
5.50  (4.83)
[4.45,  6.80]
5.81 (5.57)
[4.63,  7.30]
44%
[35%,  55%]
54%
[45%,  62%]
57%
[45%,  64%]
53%
[41%,  63%]
1.09
[.72,  1.45]
1.38
[.99,  1.74]
1.36
[.98,  1.73]
1.21
[.84,  1.57]
Secondary Outcomes
Depression  Symptomsb
CG-CBT  (n  =  23) 13.13  (4.70)
[11.34,  15.21]
7.87  (5.13)
[6.02, 10.27]
6.65  (5.23)
[4.81, 9.18]
6.48  (3.93)
[5.05,  8.31]
6.46  (5.73)
[4.86,  8.57]
40%
[225,54%]
49%
[30%,  63%]
51%
[37%,  62%]
51%
[35%,  63%]
1.07
[.43,  1.67]
1.30
[.65,  1.92]
1.54
[.85,  2.16]
1.27
[.62,  1.88]
.05
[−.60,  .70]
−.15
[−.80,  .50]
−.18
[−.83,  .48]
−.37
[−1.02,  .29]
SG-CBT (n  =  15)  13.13  (4.76)
[10.94,  15.77]
7.64  (4.49)
[5.67,  10.29]
7.47  (5.58)
[5.12, 10.90]
7.33  (5.73)
[4.93,  10.90]
8.82 (7.09)
[5.87,  13.24]
42%
[22%,  57%]
43%
[17%,  61%]
44%
[17%,  62%]
33%
[−1%,  55%]
1.19
[.38,  1.93]
1.09
[.30, 1.83]
1.10
[.31,  1.84]
.71
[−.04,  1.43]
Generalised Anxiety  Symptomsc
CG-CBT  (n  =  24)  13.67  (4.31)
[12.05,  15.51]
8.35  (5.05)
[6.55,  10.64]
7.07  (4.80)
[5.40,  9.27]
6.70  (5.00)
[4.97,  9.04]
6.77 (4.46)
[5.20,  8.82]
39%
[22%,  52%]
48%
[32%,  61%]
51%
[34%,  64%]
50%
[35%,  62%]
1.13
[.51,  1.72]
1.45
[.79,  2.06]
1.49
[.83,  2.11]
1.57
[.90,  2.19]
.23
[−.35,
.80]
−.14
[−.71,
.43]
.17
[−.40,
.74]
−.34
[−.91,
.24]SG-CBT (n  =  23) 12.96  (4.17)
[11.36,  14.78]
7.19  (5.13)
[5.38,  9.63]
7.74  (4.46)
[6.11, 9.81]
5.81  (5.28)
[4.01,  8.41]
8.44  (5.32)
[6.52,  10.93]
44%
[26%,  59%]
40%
[24%,  53%]
55%
[35%,  69%]
35%
[16%,  50%]
1.23
[.58,  1.84]
1.21
[.56,  1.82]
1.50
[.83,  2.13]
.95
[.32,  1.54]
Social Anxiety  Symptoms d
CG-CBT  (n  =  23)  8.31  (2.49)
[7.35,  9.38]
5.32  (3.21)
[4.16,  6.81]
4.29  (2.93)
[3.25, 5.67]
4.41  (3.26)
[3.26,  5.95]
4.23 (3.26)
[3.09,  5.78]
36%
[18%,  50%]
48%
[32%,  61%]
47%
[28%,  61%]
49%
[30%,  63%]
1.04
[.41,  1.64]
1.48
[.80, 2.10]
1.34
[.68,  1.96]
1.41
[.74,  2.03]
−.60
[−1.24,  .06]
−.70
[−1.34,  −.03]
−.39
[−1.03,  .26]
−.70
[−1.34,  −.03]
SG-CBT (n  =  16) 8.38  (2.36)
[7.29,  9.62]
7.12  (2.64)
[5.93,  8.54]
6.31  (2.84)
[5.06, 7.86]
5.61  (2.76)
[4.41,  7.14]
6.56 (3.48)
[5.06,  8.51]
15%
[−2%,  29%]
25%
[6%, 40%]
33%
[15%,  47%]
22%
[−2%,  40%]
.50
[−.21,  1.19]
.79
[.05  t  01.49]
1.08
[.31,  1.79]
.61
[−.11,  1.30]
Tertiary Outcomes
Disability and  Functioning  (SDS)
CG-CBT  (n  =  72)  12.07  (8.65)
[10.23, 14.25]
8.01  (7.98)
[6.36,  10.09]
6.28  (6.53)
[4.94, 7.99]
5.59  (6.36)
[4.29,  7.28]
5.65 (7.04)
[4.25,  7.53]
34%
[16%,  47%]
48%
[34%,  59%]
54%
[40%,  64%]
53%
[38%,  65%]
.49
[.15,  .82]
.76
[.41,  1.09]
.85
[.51,  1.19]
.81
[.47,  1.15]
.05
[−.28,  .37]
.13
[−.20,  .45]
.01
[−.32,  .33]
.05
[−.28,  .37]
SG-CBT (n  =  73) 11.80  (7.69)
[10.16, 13.69]
7.68  (6.49)
[6.33,  9.32]
5.50  (5.47)
[4.38,  6.91]
5.54  (6.58)
[4.22,  7.26]
5.33 (7.09)
[3.93,  7.22]
35%
[21%,  46%]
53%
[41%,  63%]
53%
[38%,  64%]
55%
[39%,  67%]
.58
[.24,  .91]
.94
[.60, 1.28]
.87
[.53,  1.21]
.87
[.53,  1.21]
Psychological Distress  (K−10)e
CG-CBT  (n  =  72)  22.03  (7.30)
[20.41, 23.78]
18.93  (6.62)
[17.46,  20.53]
17.32  (6.19)
[15.95,  18.82]
16.62  (6.02)
[15.29,  18.07]
–  26%
[12%,  38%]
39%
[27%,  51%]
45%
[33%,  56%]
–  .44
[.10,  .77]
.57
[.23,  .90]
.70
[.36,  1.03]
–  −.01
[−.33,  .32]
−.13
[−.46,  .19]
−.11
[−.44,  .21]
–
SG-CBT (n  =  73) 22.92  (7.43)
[21.28,  24.68]
18.98  (6.32)
[17.58,  20.48]
18.19  (6.84)
[16.69,  19.83]
17.34  (6.58)
[15.89,  18.91]
–  31%
[19%,  41%]
37%
[24%,  48%]
43%
[31%,  54%]
–  .57
[.24,  .90]
.66
[.33,  .99]
.80
[.45,  1.13]
–
Neuroticism (NEO-FFI-N)
CG-CBT  (n  =  72)  28.17  (7.72)
[26.45  30.00]
25.85  (7.98)
[24.07 27.75]
23.92  (8.65)
[22.01  26.00]
22.31  (8.49)
[20.44  24.35]
–  8%
[1%,  15%]
15%
[8%  to22%]
21%
[14%,  27%]
–  .30
[−.03,  .62]
.52
[.18,  .85]
.72
[.38,  1.06]
–  −.16
[−.49,  .16]
−.29
[−.61,  .04]
−.26
[−.58,  .07]
–
SG-CBT (n  =  73)  28.81  (8.97)
[26.82  30.94]
27.24  (8.97)
[25.27  29.37]
26.37  (8.37)
[24.52  28.36]
24.51  (8.63)
[22.60  26.58]
–  5%  [−2%,  12%]  8%
[2%,15%]
15%
[8%,  22%]
–  .18
[−.15,  .50]
.28
[−.05,  .61]
.49
[.16  to.82]
–
Note: Standard deviations are shown in rounded parentheses for the means and 95% conﬁdence intervals are shown in square parentheses. Percentage reductions derived from the model change factor (i.e., 1 − exp()) in the
model.  Panic, depression, generalised anxiety, and social anxiety symptoms were measured with the PDSS-SR, PHQ-9, GAD-7, and MINI-SPIN, respectively.
a Analyses use the data of participants meeting diagnostic criteria for Panic Disorder at assessment.
b Analyses use the data of participants meeting diagnostic criteria for Major Depressive Disorder at assessment.
c Analyses use the data of participants meeting diagnostic criteria for Generalised Anxiety Disorder at assessment.
d Analyses use the data of participants meeting diagnostic criteria for Social Anxiety Disorder at assessment.
e To accurately reﬂect percentage change, a constant of 10 was subtracted from K10 scores when calculating percentage change scores.
nxiety
(
S
S
t
(
f
g
p
w
3
n
n
W
W
X
i
p
i
b
3
i
H
p
3
t
a
T
a
X
X
a
p
p
t
g
r
n
T
n
3
d
(
p
p
t
t
t
c
i
o
p
4
t
C
s
s
c
CV.J. Fogliati et al. / Journal of A
MINI-SPIN: Wald’s X2 = 56.05, p < .001), and a signiﬁcant Time by
upport Format interaction for social anxiety symptoms (MINI-
PIN: Wald’s X2 = 10.40, p =0.034). Pairwise comparisons indicated
hat both groups improved from baseline to post-treatment
p < .001) and that the CG-CBT group further improved to 3-month
ollow-up (p = .03). Pairwise comparisons revealed the CG-CBT
roup reported slightly lower symptoms at 3-month (M diff = 2.02;
 = .031) and 24-month follow-up (M diff = 2.33; p = .034) compared
ith the SG-CBT group.
.2.2. Outcomes for disability, general psychological distress, and
euroticism. Across the whole sample (n = 145) there were sig-
iﬁcant main effects for Time on measures of disability (SDS:
ald’s X2 = 164.64, p < .001), general psychological distress (K-10:
ald’s X2 = 138.17, p < .001), and neuroticism (NEO-FFI-N: Wald’s
2 = 95.26, p < .001), but no signiﬁcant Time by Treatment Approach
nteractions (SDS: Wald’s X2 = .90, p = .924; K-10: Wald’s X2 = 1.04,
 = .793; NEO-FFI-N: Wald’s X2 = 4.93, p = .177). Pairwise compar-
sons indicated that, on all measures, both groups improved from
aseline to post-treatment (ps < .001) and from post-treatment to
-month follow-up (ps < .01). There was also a further signiﬁcant
mprovement to 12-month follow-up on neuroticism (ps < .001).
owever, there were no differences between the groups at any time
oint.
.3.3. Changes in diagnostic status. The numbers and changes in
he proportion of participants meeting formal diagnostic criteria
t initial assessment and 3-month follow-up are shown in Table 4.
he GEE analyses of diagnoses revealed a signiﬁcant effect for Time
cross the diagnoses (PD: Wald’s X2 = 68.74, p < .001; MDE; Wald’s
2 = 18.48, p < .001; GAD: Wald’s X2 = 25.86, p < .001; SAD: Wald’s
2 = 23.15, p < .001). No signiﬁcant Time by Support Format inter-
ctions were observed for any diagnoses (PD: Wald’s X2 = 0.11,
 = .731; MDE: Wald’s X2 = 0.95, p = .328; GAD: Wald’s X2 = 1.12,
 = .290; SAD: Wald’s X2 = 0.17, p = .676) indicating that the propor-
ion of participants meeting diagnostic criteria reduced across both
roups.
The GEE analyses focusing on average comorbid diagnoses
evealed a signiﬁcant Time effect (Wald’s X2 = 105.26, p < .001) but
o Time by Support Format interaction (Wald’s X2 = 0.70, p = .401).
hese analyses indicated signiﬁcant reductions in comorbid diag-
oses amongst both groups over time.
.3.4. Treatment completion and satisfaction rates. There was  no
ifference in the number of lessons completed by the CG-CBT
M = 4.35; SD = 1.15) and SG-CBT (M = 4.27; SD = 1.25) groups at
ost-treatment (F1,145 = .13, p = .714). Of the participants who com-
leted the evaluation questions at post-treatment, 96% (54/56) of
he CG-CBT group, and 100% (62/62) of the SG-CBT group, reported
hey would recommend the course to others. Further, 93% (52/56) of
he CG-CBT group and 95% (59/62) of the SG-CBT group reported the
ourse was worth their time. There were no signiﬁcant differences
n the proportions of participants willing to recommend the course
r ﬁnding the course was worth their time (X2 range: .28–2.25;
 = .133–.597).
. Discussion
The present study is one of four in a series of RCTs designed
o compare internet-delivered TD-CBT and DS-CBT as well as CG-
BT and SG-CBT for several common mental disorders. The current
tudy focused on comparing these two treatment approaches and
upport formats for adults with principal PD and several common
omorbid disorders. It was hypothesised that both TD-CBT and DS-
BT would result in signiﬁcant reductions in principal symptoms Disorders 39 (2016) 88–102 99
of PD, but that TD-CBT would be superior at reducing symptoms
of comorbid MDD, GAD and SAD at each time point. It was  also
hypothesised that CG-CBT would be superior to SG-CBT at every
time point for both symptoms of PD and symptoms of comor-
bid disorders. These hypotheses were only partially supported. All
conditions were associated with large improvements in principal
PD symptoms and moderate-to-large improvements on comorbid
symptoms of MDD, GAD and SAD. However, no marked or con-
sistent differences were found across the post-treatment, 3, 12
or 24-months follow-up time points between TD-CBT and DS-CBT
groups or the CG-CBT and SG-CBT groups. The present study pro-
vides support for both treatment approaches and support formats
in the treatment of principal PD and the comorbid disorders of
interest.
The ﬁndings of the present study are consistent with the ﬁndings
of the other three RCTs in this series of studies comparing TD-CBT
and DS-CBT (Dear, Gandy et al., 2015; Dear, Staples et al., 2015;
Dear, Zou et al., 2015; Titov, Dear, Staples, Bennett-Levy et al., 2015;
Titov, Dear, Staples, Terides et al., 2015; Dear et al., submitted), but
extends these results to PD. Encouragingly, the present study found
evidence of large overall reductions in symptoms of PD (Cohen’s
d ≥ 0.71; avg. reduction ≥ 36%) and moderate-to-large reductions
in symptoms of comorbid MDD  (Cohen’s d ≥ 0.71; avg. reduc-
tion ≥ 33%), GAD (Cohen’s d ≥ 0.91; avg. reduction ≥ 34%) and SAD
(Cohen’s d ≥ 0.50; avg. reduction ≥ 15%). These reductions were
reﬂected in marked reductions in the percentages of participants
meeting diagnostic criteria for PD (i.e., ≥ 47%), MDD (i.e., ≥ 78%),
GAD (i.e., ≥ 50%) and SAD (i.e., ≥ 57%) across the groups. These
ﬁndings are broadly consistent with those observed in other
internet-delivered trials of CBT for PD (Klein et al., 2006; Richards,
Klein, & Austin, 2006; Kiropoulos et al., 2008) as well as face-to-
face trials of CBT for PD (Butler et al., 2006; Stewart & Chambless,
2009; Sánchez-Meca et al., 2010; Hoffman et al., 2012). Impor-
tantly, sustained improvements were also found across all groups
on measures of neuroticism, psychological distress, and disability,
indicating the beneﬁts of treatment generalised to other domains.
The ﬁndings of the present study therefore highlight the potential
of both treatment approaches and support formats for the internet-
delivered CBT treatment of principal PD.
The present study is the largest (n = 135) to the authors’ knowl-
edge to compare TD-CBT and DS-CBT for principal PD and it is
noteworthy that it found the two  treatment approaches to be
associated with similar improvements in panic symptoms. The
few other studies to compare these treatment approaches have
involved relatively small numbers (n < 15) of participants with
PD (e.g., (Ellard et al., 2010; Farchione et al., 2012; Norton &
Barrera, 2012) and, in contrast to the current study, the next largest
study (n = 65) found evidence supporting the superiority of a more
disorder-speciﬁc approach (Craske et al., 2007). However, there
are key differences between the transdiagnostic approach used in
that study and most other studies to date. Speciﬁcally, that study
(Craske et al., 2007) allowed clinicians to ‘stray’ from targeting the
principal PD diagnosis by applying a second disorder-speciﬁc treat-
ment protocol to the most severe comorbid disorder; thus, in effect,
applying two  disorder-speciﬁc treatments. In contrast, the current
study used a single and broader transdiagnostic treatment protocol
that was provided to all participants irrespective of their diagnos-
tic proﬁle. One possibility is that having clinicians use multiple
disorder-speciﬁc treatment protocols to form a more transdiag-
nostic treatment ‘dilutes’ therapeutic effects; that is, compared to
learning one treatment protocol and set of treatment principles,
which can be applied regardless of the nature of the emotional
problem. If replicated, the ﬁndings of the current study are impor-
tant given the pragmatic advantages of TD-CBT in attempts to
disseminate effective psychological treatments (McHugh, Murray,
& Barlow, 2009). Yet, it has to be noted that the current ﬁndings
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lso support the longstanding observation that disorder-speciﬁc
reatments also have substantial transdiagnostic treatment effects
Brown, Antony, & Barlow, 1995; Tsao, Mystkowski, Zucker, &
raske, 2002). Thus, as mentioned elsewhere, the key criteria used
o inform the decisions between using TD-CBT and DS-CBT may  be
ore pragmatic than clinical when it comes to the treatment of
ommon and highly comorbid mental disorders.
The ﬁndings of the current study are also consistent with the
ther studies in this series, which found clinician-guided and
elf-guided iCBT result in similar clinical outcomes for principal
DD, GAD and SAD (Dear, Gandy et al., 2015; Dear, Staples et al.,
015; Dear, Zou et al., 2015; Titov, Dear, Staples, Bennett-Levy
t al., 2015; Titov, Dear, Staples, Terides et al., 2015; Dear et al.
ubmitted). These ﬁndings are also consistent with the few other
tudies in the literature to directly compare newer-generation
linician-guided and self-guided iCBT interventions, and which
ave found similar outcomes for both support formats (Berger,
aspar, et al., 2011; Berger, Hämmerli, et al., 2011; Titov et al.,
013; Dear, Gandy et al., 2015; Dear, Staples et al., 2015; Dear,
ou et al., 2015). However, these ﬁndings are inconsistent with
hose of meta-analyses in the area that have compared across
tudies and that have found clinician-guided iCBT to be associ-
ted with higher completion rates and greater clinical outcomes
Andersson & Cuijpers, 2009; Cuijpers et al., 2009). Unfortunately,
here is still very limited empirical data about the essential com-
onents and clinical processes required for efﬁcacious, safe and
cceptable internet-delivered treatment, which makes it difﬁcult
o explain discrepancies in ﬁndings between studies. However,
t is important to note that studies ﬁnding self-guided iCBT to
e equally efﬁcacious have typically employed highly developed
reatment protocols (i.e., developed over numerous clinical tri-
ls), been conducted by specialised clinical research units (i.e.,
ith signiﬁcant experience in internet-delivered treatment), have
nvolved some kind of therapist-administered screening assess-
ent prior to treatment (i.e., to orient patients to the treatment)
nd have included measures, such as regular automatic emails,
imed at engaging patients throughout treatment. More research
s needed to identify the essential components and clinical pro-
esses required for effective, safe and acceptable clinician-guided
nd self-guided iCBT treatments. This is a critical area for future
esearch which will likely explain some of the differences cur-
ently being observed between studies whilst also informing the
evelopment and use of optimally effective clinician-guided and
elf-guided internet-delivered treatments. However, the present
ndings add to emerging studies in highlighting the potential of
arefully designed and delivered iCBT treatments for increasing
ccess to effective treatment and reducing the burden of common
ental health disorders (Kazdin, 2015).
As with all studies the present study has a number of limita-
ions and design features that need to be carefully considered when
nterpreting its ﬁndings. The main limitations of the current study
re the absence of a control group, the use of a superiority trial
esign and the difﬁculties experienced in recruiting the target num-
er of participants with principal PD and comorbid MDD, GAD and
AD. The absence of a control group means that it is not possible
o control for the general effects of time and spontaneous remis-
ion. The use of a superiority trial design means that signiﬁcant
aution is needed in considering any statistical ﬁndings from the
urrent as supporting true clinical equivalence, which requires the
se of speciﬁc analyses. The failure to recruit the target number of
articipants (target n = 200; actual n = 135) means that the present
tudy was only powered to detect moderate to large differences
n the primary outcome of PD symptoms and large differences
n comorbid symptoms of MDD, GAD and SAD. It also means that
stimates of clinical effects are unlikely to be as accurate or reli-
ble as those observed in the larger studies in this series of studies Disorders 39 (2016) 88–102
(Dear, Gandy et al., 2015; Dear, Staples et al., 2015; Dear, Zou et al.,
2015; Titov, Dear, Staples, Bennett-Levy et al., 2015; Titov, Dear,
Staples, Terides et al., 2015; Dear et al. submitted). It is important
to bear in mind that, although a study may  have a sufﬁcient sam-
ple size to detect a difference of a certain magnitude, much larger
sample sizes are often needed to obtain stable estimates of effects
that are not disproportionately inﬂucenced by positive or nega-
tive outliers. Indeed, potentially reﬂecting this, several signiﬁcant
higher order interactions were observed in the current study that
were not observed in the other larger studies in this series and yet,
on closer examination, did not reﬂect marked or sustained differ-
ences between the conditions; that is, they emerged at only one or
two time points. However, previous literature has noted the unique
challenge of obtaining sufﬁcient sample sizes to comprehensively
compare transdiagnostic and disorder-speciﬁc treatments, given
that these clinical trials require sufﬁcient participants with both
the principal disorder of interest as well as any comorbid disorders
of interest (Titov et al., 2012).
Other limitations include resource constraints that meant it was
not possible to blind the diagnostic assessments as well as the
limited clinician time spent supporting patients in the clinician-
guided treatment group. It is possible that differences between
the clinician-guided and self-guided treatment groups may have
emerged had the clinicians had more time to support patients;
however, it is important to note there was  signiﬁcant variability in
the amount of clinician time participants wanted and the clinicians
were permitted to spend more time with participants where clini-
cally indicated. It is also possible that differences would have been
observed had the current study not employed a newer-generation
self-guided iCBT treatment and, for example, participants were pro-
vided with a more basic self-guided iCBT treatment that did not
involve an initial assessment, patient safety monitoring, the avail-
ability of technical support or the use of automatic emails to guide
and engage patients throughout treatment. It is also important to
note that, as with most studies, a meaningful proportion of partici-
pants continued to experience clinical-level symptoms and to meet
diagnostic criteria for disorders following treatment. One interest-
ing avenue for future research could be to examine stepped-care
models of internet-delivered treatment where participants start
with more self-guided and lower-intensity treatments initially and,
with the goal of improving clinical outcomes, are ‘stepped up’
to more intensitve and clinician-guided internet-delivered treat-
ments based on clinical need. Nevertheless, the current study has a
number of notable strengths including employing the largest sam-
ple of participants with principal PD to date as well as high retention
rates, long-term follow-up and the use of multiple outcomes (e.g.,
clinical symptoms, diagnostic assessments, satisfaction rates and
treatment completion) to compare the two  treatment approaches
and two  support formats.
The present study found signiﬁcant clinical improvements and
high levels of treatment satisfaction among adults with principal PD
for both transdiagnostic and disorder-speciﬁc CBT delivered with
and without clinician contact during treatment. Clinical improve-
ments were observed in panic symptoms as well as symptoms of
MDD, GAD and SAD immediately post-treatment and were main-
tained at 3, 12 and 24-month follow-up. Clinical improvements
in symptoms were also reﬂected in reduced proportions of par-
ticipants meeting diagnostic criteria for PD, MDD, GAD and SAD
at 3-month follow-up. No marked or consistent differences were
observed in the clinical outcomes, satisfaction rates or treatment
completion rates whether participants received TD-CBT or DS-CBT
or whether they received CG-CBT or SG-CBT. Thus, the present
study joins the other studies in this series, in highlighting the public
health potential of carefully designed and delivered transdiagnostic
and disorder-speciﬁc treatments delivered for principal PD as well
nxiety
a
m
D
d
m
d
p
b
A
i
f
C
A
R
A
A
A
A
A
A
B
B
B
B
B
B
C
C
C
C
C
C
CV.J. Fogliati et al. / Journal of A
s the potential to successfully provide internet-delivered treat-
ent in clinician-guided and self-guided formats.
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